In 2013, this group reported that the versican 3′UTR induces the development of hepatocellular carcinoma (HCC) and demonstrated that the versican 3′UTR can increase the expression of versican, CD34, and fibronectin via a ceRNA mechanism in HCC cells [38]. The gene discussed is CD34; the disease is hepatocellular carcinoma.